Pasar al contenido principal

EXPLOTANDO LA INFORMACION GENOMICA DEL PATOGENO PARA IDENTIFICAR NUEVOS DETERMINANTES DEL EXITO O FRACASO DEL TRATAMIENTO EN TUBERCULOSIS

PID2022-137607OB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 6
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Tesis doctoral (DoctoralThesis)

Culture-Free Sequencing of Mycobacterium Tuberculosis for Diagnosis and Genetic Diversity Identification

  • Mariner Llicer, Carla
[ES] La detección y diagnóstico de resistencias en Mycobacterium tuberculosis (MTB) supone un reto para el control de la tuberculosis (TB). La técnica diagnóstica implica el cultivo de muestras diagnósticas, pero este proceso es lento y retrasa los resultados hasta meses demorando la prescripción del tratamiento óptimo. El cultivo también se utiliza para enriquecer muestras diagnósticas con fines de investigación, como la secuenciación del genoma de MTB. Sin embargo, se desconoce si cultivar reduce la diversidad genética de la muestra diagnóstica, sesgando los resultados. Actualmente, las técnicas moleculares permiten evitar el cultivo en el diagnóstico, detectando resistencia a antibióticos más rápidamente, pero se limitan a identificar las mutaciones comunes asociadas a la resistencia a la rifampicina (RIF) e isoniazida (INH), los fármacos de primera línea. No obstante, la composición compleja de las muestras diagnósticas como el esputo sigue siendo un desafío para la secuenciación. Esta tesis presenta técnicas y estrategias de secuenciación para recuperar MTB a partir de esputos, centrándose en la diversidad genética en esputos y cultivos y explorando el potencial de la secuenciación para determinar resistencias. En el Capítulo 1 comparamos la diversidad genética entre pares de esputos y cultivos en dos entornos diferentes. Desarrollamos una técnica de secuenciación de esputos, realizando una secuenciación directa o enriquecida según la cantidad de MTB presente. Además, implementamos un flujo de análisis para descartar artefactos del procesamiento de muestras. Los resultados muestran una alta concordancia en la diversidad entre esputos y cultivos, cuestionando la hipótesis inicial del cuello de botella en el cultivo. En el Capítulo 2 exploramos las limitaciones del Gene Xpert MTB/RIF Ultra (XpertUltra) para identificar mutaciones de resistencia a RIF, examinando las mutaciones de resistencia más prevalentes en el sur de Mozambique. Utilizamos la secuenciación del genoma completo para identificar variantes de resistencia en cepas recolectadas en Manhiça, Mozambique. Detectamos dos cepas con mutaciones de resistencia a RIF no identificadas por el XpertUltra y una alta prevalencia de cepas resistentes a INH sin resistencia a RIF (no multirresistentes, MDR). Los resultados sugieren que el XpertUltra podría no detectar algunos casos de resistencia a RIF y/o INH, destacando la necesidad de incluir nuevas mutaciones en las pruebas moleculares. En el Capítulo 3 evaluamos el potencial de la secuenciación de amplicones para predecir la resistencia a antibióticos e identificar el linaje de las cepas. Diseñamos un panel de nueve genes asociados a la resistencia a siete antibióticos y dos regiones filogenéticas, poniendo a punto una PCR multiplex para amplificar todas las regiones en una sola reacción. A diferencia de otros paneles, los cebadores diseñados cubren los genes completos para detectar todas las mutaciones presentes. La secuenciación se realiza con MinION (Nanopore), una plataforma portátil con análisis en tiempo real. Comparamos las variantes obtenidas con las de Illumina para calibrar los parámetros del llamado de variantes y evitar falsos positivos. Los resultados muestran una alta correlación entre MinION e Illumina en la detección de resistencia e identificación de linajes, independientemente del tipo de muestra. Estos resultados, junto con el análisis en tiempo real de MinION, son prometedores para su implementación en atención primaria. En conclusión, esta tesis contribuye a los avances en la genómica de muestras diagnósticas. Por un lado, demostrando que el cultivo refleja la diversidad genética del esputo, y por otro, revelando el potencial de la secuenciación del genoma y de amplicones para predecir resistencia a antibióticos. Las técnicas y resultados que se presentan contribuirán a promover la secuenciación directa de esputo como técnica de diagnóstico rápida y precisa, pero también su uso para la investigación., [CA] La detecció i diagnòstic de resistències en Mycobacterium tuberculosis (MTB) suposa un repte per al control de la tuberculosi (TB). La tècnica de referència ha estat el cultiu de mostres diagnòstiques, però aquest procés és lent, retardant els resultats durant setmanes o mesos i dificultant la prescripció d'un tractament òptim. El cultiu també s'ha utilitzat per enriquir mostres diagnòstiques amb finalitats de recerca, com la seqüenciació del genoma de MTB. No obstant això, encara es desconeix si el cultiu redueix la diversitat genètica de la mostra diagnòstica, cosa que podria generar un biaix en els resultats. Actualment, les tècniques moleculars han permès evitar el cultiu en el diagnòstic, detectant resistència a antibiòtics més ràpidament, però es limiten a identificar les mutacions comunes associades a resistència a la rifampicina (RIF) i isoniazida (INH), els fàrmacs de primera línia. Tanmateix, la composició complexa de les mostres diagnòstiques com l'esput segueix sent un repte per a la seqüenciació. Aquesta tesi presenta tècniques i estratègies de seqüenciació per recuperar MTB a partir d'esputs, centrant-se en la diversitat genètica en esputs i cultius i explorant el potencial de la seqüenciació per determinar resistències. Al Capítol 1 comparem la diversitat genètica entre parelles d'esputs i cultius en dos entorns diferents. Desenvolupem una tècnica de seqüenciació d'esputs, realitzant una seqüenciació directa o enriquida segons la quantitat de MTB present. A més, implementem un flux d'anàlisi per descartar artefactes del processament de mostres. Els resultats mostren una alta concordança en la diversitat entre esputs i cultius, qüestionant la hipòtesi inicial d'un coll de botella al cultiu. Al Capítol 2 explorem les limitacions de la prova molecular Gene Xpert MTB/RIF Ultra (XpertUltra) per identificar mutacions de resistència a RIF, examinant les mutacions de resistència més prevalents al sud de Moçambic. Utilitzem la seqüenciació del genoma complet per identificar variants de resistència a antibiòtics en soques recol·lectades a Manhiça, Moçambic. Detectem dues soques amb mutacions de resistència a rifampicina no identificades per l'XpertUltra i una alta prevalença de soques resistents a INH sense resistència a RIF (no multiressistents, MDR). Els resultats sugereixen que l'XpertUltra pot no detectar alguns casos de resistència a RIF i/o INH, destacant la necessitat d'incloure noves mutacions en proves moleculars. Al Capítol 3 avaluem el potencial de la seqüenciació d'amplicons per predir resistència a antibiòtics i identificar el llinatge de les soques. Dissenyem un panell de nou gens associats a resistència a set antibiòtics i dues regions filogenètiques, posant a punt una PCR multiplex per amplificar totes les regions en una sola reacció. A diferència d'altres panells, els encebadors dissenyats cobreixen els gens complets, per detectar totes les mutacions presents. La seqüenciació es realitza amb MinION (Nanopore), una plataforma portàtil amb anàlisi en temps real. Comparem les variants obtingudes amb les d'Illumina per calibrar paràmetres per cridar de variants i evitar falsos positius. Els resultats mostren una alta correlació entre MinION i Illumina en la detecció de resistència i identificació de llinatges, independentment del tipus de mostra. Aquests resultats, juntament amb l'anàlisi en temps real de MinION, són prometedors per a la seva implementació en atenció primària. En conclusió, aquesta tesi contribueix als avanços en la genòmica directa de mostra diagnòstica. D'una banda, demostrant que el cultiu reflecteix la diversitat genètica de l'esput i, d'altra banda, revelant el potencial de la seqüenciació del genoma i d'amplicons per predir resistència a antibiòtics. Els resultats obtinguts superen les limitacions de les proves moleculars actuals, i les tècniques presentades podrien promoure la seqüenciació directa d'esput com a eina de diagnòstic ràpida i precisa, així com per a la investigació., [EN] Mycobacterium tuberculosis (MTB) detection and diagnosis of drug resistance(DR) have been a challenge for tuberculosis(TB) control. Culturing mycobacteria from diagnostic samples has been the most commonly used diagnostic technique. However, culturing depends on MTB's slow growth, delaying results and the prescription of optimal treatment for weeks to months. Culture is also essential for research purposes such as MTB genomics. However, it remains unclear whether it causes a bottleneck in the sample's original genetic diversity, potentially biasing results. Skipping the culturing step has been possible with the introduction of molecular techniques in surveillance systems. These reduce turnaround time and allow MTB and DR detection through a single assay. However, such tests are limited to detecting common mutations associated with rifampicin(RIF) and isoniazid(INH) resistance. Moreover, the complex composition of diagnostic samples, like sputum, continues to challenge sequencing workflows in research. In this thesis, we explore different sequencing approaches to recover and sequence MTB from sputum samples, focusing on overcoming the hypothesized culture bottleneck and evaluating the potential of sequencing for DR prediction. In Chapter 1, we compare genetic diversity within sputum-culture paired samples in two settings. We implement a culture-free sequencing (cfWGS) approach for sputum, using both direct and enriched sequencing, depending on the initial amount of MTB DNA. We also develop an analysis pipeline to filter artifactual variants from cfWGS approaches. To generalize results, three additional datasets are reanalyzed. The results show high concordance in genetic diversity between sputum-culture pairs, both in terms of presence and frequency of variants. These results contradict the initial culture bottleneck assumption, emphasizing the importance of tailored filtering steps depending on sample complexity. In Chapter 2, we explore the limitations of the Gene Xpert MTB/RIF Ultra (XpertUltra) for detecting non-common mutations and screen for prevalent DR mutations in southern Mozambique. We use WGS to identify DR variants in strains collected in Manhiça (Mozambique) during two time periods. Two strains were found to harbor RIF resistance mutations beyond XpertUltra's detection scope. We also detect a high prevalence of INH-resistant strains without RIF resistance (non-MDR TB). This suggests that XpertUltra, the primary diagnostic tool in the region, sometimes misclassifies RIF-resistant cases, highlighting the need for expanded drug and mutation coverage in molecular diagnostic tests. In Chapter 3, we assess the potential of targeted sequencing for DR prediction and lineage identification by designing a gene panel of 9 genes associated with resistance to 7 drugs and two phylogenetic regions. We develop a multiplex PCR to amplify all target regions in one reaction. Unlike other commercial panels, our primers cover entire genes allowing the identification of all mutations, not just those in hotspot regions. We employ the portable MinION (Nanopore) platform, which provides real-time analysis. A key aim is to calibrate parameters for MinION variant calling by comparing its results to Illumina sequencing, establishing a frequency cut-off to avoid false positives due to MinION's error rate. Our results show high concordance between MinION and Illumina in detecting DR and genotyping, regardless of the sample type. These findings present a significant advantage for future implementation in point-of-care systems. This thesis advances the field of cfWGS by confirming that culture mirrors sputum's genetic diversity and demonstrating the potential of whole genome and targeted sequencing to overcome the limitations of current molecular diagnostic tests in predicting DR. The techniques and findings presented could help promote cfWGS as a front-line approach for faster, more accurate diagnosis, and contribute to further research., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00; Fundació La Caixa: HR21-00415, International Science and Technology Center (ISTC): Project #G-2143 and National Institute of Allergy and Infectious Diseases (NIH). This work was also supported by STOP TB partnership [STBP/TBREACH/GSA/W5-30: CA-3-D000920001], the TB Portals programme of the National Institutes of Health, the European Research Council [101001038-TB-RECONNECT: H2020-ERC-COG/0800 and 638553-TB-ACCELERATE], Generalitat Valenciana [AICO/2018/113], the Spanish Ministry of Science and Innovation [PID2019-104477RB-I00] and the Ministerio de Economía, Indústria y Competividad (SAF2016-77346-R)
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic diversity within diagnostic sputum samples is mirrored in the culture of Mycobacterium tuberculosis across different settings

  • Mariner-Llicer, Carla
  • Goig, Galo A.
  • Torres-Puente, Manuela
  • Vashakidze, Sergo
  • Villamayor, Luis M.
  • Saavedra-Cervera, Belen
  • Mambuque, Edson
  • Khurtsilava, Iza
  • Avaliani, Zaza
  • Rosenthal, Alex
  • Gabrielian, Andrei
  • Shurgaia, Marika
  • Shubladze, Natalia
  • García-Basteiro, Alberto L.
  • López, Mariana G.
  • Comas, Iñaki
11 páginas, 6 figuras, Culturing and genomic sequencing of Mycobacterium tuberculosis (MTB) from tuberculosis (TB) cases is the basis for many research and clinical applications. The alternative, culture-free sequencing from diagnostic samples, is promising but poses challenges to obtain and analyse the MTB genome. Paradoxically, culture is assumed to impose a diversity bottleneck, which, if true, would entail unexplored consequences. To unravel this paradox we generate high-quality genomes of sputum-culture pairs from two different settings after developing a workflow for sequencing from sputum and a tailored bioinformatics analysis. Careful downstream comparisons reveal sources of sputum-culture incongruences due to false positive/negative variation associated with factors like low input MTB DNA or variable genomic depths. After accounting for these factors, contrary to the bottleneck dogma, we identify a 97% variant agreement within sputum-culture pairs, with a high correlation also in the variants' frequency (0.98). The combined analysis from five different settings and more than 100 available samples shows that our results can be extrapolated to different TB epidemic scenarios, demonstrating that for the cases tested culture accurately mirrors clinical samples., This work has been supported by the following: European Research Council (ERC): H2020-ERC-COG/0800; Ministerio Español de Ciencia e Innovación: PID2022-137607OB-I00 and Fundació La Caixa: HR21-00415 received by I.C; Stop TB partnership (TB REACH): STBP/ TBREACH/GSA/W5-30 received by A.G.B; and International Science and Technology Center (ISTC): Project #G-2143; National Institute of Allergy and Infectious Diseases (NIH) received by N.S. We would like to thank Katharine Walter for reviewing the manuscript and providing her feedback, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genomic determinants of antibiotic resistance for Helicobacter pylori treatment: a retrospective phenotypic and genotypic observational study

  • Martínez-Martínez, Francisco José
  • Chiner-Oms, Álvaro
  • Furió, Victoria
  • Yamaoka, Yoshio
  • Dekker, John P.
  • Mégraud, Francis
  • Benejat, Lucie
  • Ducournau, Astrid
  • Giese, Alban
  • Jehanne, Quentin
  • Jauvain, Marine
  • Camargo, M. Constanza
  • Comas, Iñaki
  • Lehours, Philippe
12 páginas, 5 figuras., Background: Rising antimicrobial resistance of Helicobacter pylori is a public health challenge. Genomic-based susceptibility testing allows for the identification of resistance-associated mutations, complementing conventional diagnostics and advancing towards pathogen-based personalised therapies. Our study aimed to identify genes and mutations involved in antimicrobial resistance in H pylori and evaluate the extent to which these markers can be used as predictors of phenotypic resistance against clarithromycin and levofloxacin. Methods: In this retrospective phenotypic and genotypic observational study, we included 1011 H pylori whole-genome sequences and strains of known geographical origin from the H pylori Genome Project (HpGP) collection. We performed phenotypic clarithromycin and levofloxacin susceptibility testing on a subset of 419 HpGP strains using Etest at a centralised laboratory. A genomic analysis was conducted to identify 23S rRNA and gyrA variants and build a curated catalogue of mutations associated with resistance to clarithromycin (ie, 23S rRNA 2142A→G, 2142A→C, and 2143A→G) and levofloxacin (ie, gyrA A88V or A88P, N87K or N87I, and D91G, D91N, or D91Y). Genotype-phenotype concordance was assessed to estimate sensitivity and specificity, and the curated catalogue of resistance-associated mutations was applied to the complete HpGP set. Region-specific prevalence of resistance-associated mutations was calculated for a combined dataset including the HpGP genomes and 768 whole-genome sequences retrieved from the US National Center for Biotechnology Information Sequence Read Archive repository. Associations between resistance genotypes, H pylori subpopulations, and minimum inhibitory concentrations (MICs) were tested. Findings: Clarithromycin-resistant and levofloxacin-resistant HpGP strains were estimated with a sensitivity and specificity of 100%, with all confidence intervals ranging from 96% to 100%. The combined analysis (n=1779) found the highest prevalence of clarithromycin resistance in the western Pacific region (173 [51·2%] of 338 in southeast Asia and 75 [29·8%] of 252 in eastern Asia), north African region (seven [38·9%] of 18), and western Asian region (12 [31·6%] of 38), whereas the highest prevalence of levofloxacin resistance was found in south Asia (14 [51·85%] of 27), Central America (48 [38·7%] of 124), eastern Europe (four [36·4%] of 11), and southern Africa (three [33·3%] of nine). Similarly, 23S rRNA and gyrA genotypes are variable across H pylori subpopulations. MIC values changed depending on the specific mutation in 23S rRNA (mean clarithromycin MIC 24·61 mg/L [95% CI 12·27-36·96] for 2143A→G and 142·25 mg/L [95% CI 77·88-206·61] for 2142A→G) and gyrA (mean levofloxacin MIC 9·66 mg/L [95% CI 6·75-12·56] for mutations on codon 91, and 27·97 mg/L [95% CI 25·82-30·11] for mutations on codon 87). Interpretation: Mutations in specific genes are reliable indicators to clarithromycin and levofloxacin resistance in H pylori, making them useful markers for the development of diagnostic assays and molecular monitoring. Our results suggest that using clarithromycin and levofloxacin empirically, without previous susceptibility testing, is unsuitable in all geographical regions covered by this study., Intramural Research Program of the US National Cancer Institute, the European Research Council, and the Spanish Ministry of Science and Innovation., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Increasing clinical and public health role of Mycobacterium tuberculosis genomics, El papel creciente de la genómica de Mycobacterium tuberculosis en la clínica y la salud pública

  • Comas, Iñaki
6 páginas, This project received funding from the Spanish Ministry of Science and Innovation (PID2022-137607OB-I00) and the Generalitat Valenciana (Project CIPROM/2023/30)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Complete genomes reveal a refined map of Mycobacterium tuberculosis genetic diversity across evolutionary scales

  • García-Marín, Ana María
  • Torres-Puente, Manuela
  • Martínez-Priego, Llucia
  • De Marco, Griselda
  • Moreno-Molina, Miguel
  • Hunt, Martin
  • Iqbal, Zamin
  • Gil-Brusola, Ana
  • López, Mariana G.
  • González-Candelas, Fernando
  • Alonso-Del-Real, Javier
  • Comas, Iñaki
20 páginas, 8 figuras, 1 tabla., Elucidating the evolution and epidemiology of Mycobacterium tuberculosis requires comprehensive characterization of its genomic diversity; however, short-read sequencing fails to resolve part of this variation. Here, we assembled 216 complete genomes from clinical isolates in the Valencia Region, Spain, using long-read sequencing. This dataset, mostly encompassing Lineage 4, provides a refined map of M. tuberculosis genetic diversity across evolutionary scales. Complete genomes uncover a median of 312 (-1 to 792) additional SNPs per pairwise comparison, revealing an estimated evolutionary rate 1.44-fold higher than that inferred from short-read mapping. This diversity is concentrated in discrete hotspots, particularly within the pe/ppe gene family, where gene conversion is a major driver of nucleotide diversity. While most PE/PPE epitopes remain highly conserved, suggesting strong purifying selection, some involved in vaccine candidates are affected by gene conversion, with unknown consequences. At the epidemiological scale, additional resolution is gained from SNPs previously masked and newly resolved indels and structural variation, refining genetic transmission networks. Finally, at the within-host level, the use of patient-specific reference genomes allows us to capture genuine diversity during infection, showing that previous approaches led to false positive calls. Together, these findings delineate the landscape of M. tuberculosis genomic diversity and provide a framework for more accurate inference of pathogen evolution, host-pathogen interactions, and transmission dynamics., This project received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Programme (Grant 101001038, TB-RECONNECT) awarded to I.C. Additional support was provided by the Spanish Ministry of Science and Innovation (PID2022-137607OB-I00) and the Generalitat Valenciana (Project CIPROM/2023/30), both also awarded to I.C., and PID2021-127919OB-I00 and PID2024-155977OB-I00 to FGC. AGM has been supported by a ‘Formación de Profesorado Universitario’ (FPU) grant (FPU19/ 04562) from the Spanish Ministry of Universities, and the Health Research 2021 Programme (TB-TARGET_HR21-00415) by LaCaixa Foundation. Work in IC’s laboratory is further supported by the European Union’s Next Generation, through CSIC’s Global Health Platform (PTI Salud Global). JAR is hired under the Generation D initiative, promoted by Red.es, an organisation attached to the Ministry for Digital Transformation and the Civil Service, for the attraction and retention of talent through grants and training contracts (MMT24-PTI-SG-01), financed by the Recovery, Transformation, and Resilience Plan through the European Union’s Next Generation funds., Peer reviewed, Sin experimentacion animal ni uso de NAMs
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intravesical mycobacteria reshape bladder and gut microbiota in a murine bladder cancer model

  • Campo-Pérez, Víctor
  • Guallar-Garrido, Sandra
  • Cabrera-Rubio, Raúl
  • Herrero-Abadía, Paula
  • Seguí-Moll, Arnau
  • Torres-Puente, Manuela
  • Cano-Jiménez, Pablo
  • Comas, Iñaki
  • Torrents, Eduard
  • Julián, Esther
13 páginas, 8 figuras, The bladder microbiota may influence tumor progression and responses to intravesical therapies, yet the effects of Mycobacterium bovis BCG instillations on bladder and gut microbiota remain unexplored. This study evaluates, for the first time, the impact of M. bovis BCG and Mycobacterium brumae, a non-pathogenic immunomodulator, on microbiota composition in bladder tissue and cecal stool of healthy and tumor-bearing mice. Mycobacterial instillations increased gut microbial richness but reduced Actinobacteria. In tumor-bearing mice, Muribaculaceae and Bacteroidaceae were enriched, while M. bovis BCG reduced Muribaculaceae and increased Rikenellaceae. In the bladder, M. brumae instillations favored Staphylococcaceae in healthy mice, while Enterococcaceae dominated most groups except M. bovis BCG-treated tumor-bearing mice. Escherichia/Shigella decreased in mycobacteria-treated tumor-bearing mice, while Burkholderia was more prevalent in untreated bladders. Notably, M. brumae increased stool alpha diversity, whereas M. bovis BCG reduced bladder richness. These findings reveal that intravesical mycobacterial therapy modulates microbiota composition across body sites, underscoring the complex host-tumor-immunotherapy interplay., R.C.-R. thanks Generalitat-Valenciana (GVA) for the grant Plan GenT-Talent Attraction program (CDEIGENT 2020). V.C.-P. and A.S.-M. acknowledge AGAUR (Generalitat de Catalunya) for their support through the FI fellowship (2019 FI_B 00320 and 2022 FI_B 00822) during the period in which this work was carried out. This research was funded by grants PID2021-122331OB-I00, PID2021-125801OB-100, PID2024-158933OB-I00, PLEC2022-009356, PID2022-137607OB-I00, and PDC2022-133577-I00 funded by MCIN/AEI/10.13039/501100011033/FEDER, UE, MycoNET (RED2018-102677-T and RED-153634-T) and the CERCA program and AGAUR-Generalitat de Catalunya (2021SGR-01545 and 2021SGR-0092). RCR thanks Generalitat-Valenciana for the grant Plan GenT project (CDEIGENT 2020-02) and the Spanish government MCIN/AEI to the IATA-CSIC as Center of Excellence Accreditation Severo Ochoa (CEX2021-001189-S/MCIN/AEI/10.13039/501100011033). E.T. is a researcher of the ICREA Academia 2025 program. E.J. is a Serra-Húnter fellow.